Cannabis company Canopy has a decade-long tailwind

Cannabis company Canopy has a decade-long tailwind

Shares of Canopy growth (CGC) are trading 30% lower since its latest quarterly results last week. However one analyst sees shares as undervalued for the Canadian cannabis company, which has shifted from medical to more recreational sales when that market was legalized in Canada almost two years ago. “Although we expect the medical market to […]